Tobacco-specific N-nitrosamine exposures and cancer risk in the Shanghai cohort study: Remarkable coherence with rat tumor sites

International Journal of Cancer

Volumn 134, Issue 10, 2014, Pages 2278-2283

  Stepanov, Irina ^a,b   Sebero, Erin ^b   Wang, Renwei ^c   Gao, Yu Tang ^d   Hecht, Stephen S ^b   Yuan, Jian Min ^c,e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d SHANGHAI CANCER INSTITUTE   (China)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

biomarkers; lung cancer; N nitrosonornicotine

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BIOLOGICAL MARKER; COTININE; NITROSAMINE; NITROSONORNICOTINE; PHENANTHRENE; PHENANTHRENE TETRAOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGUS CANCER; EXPOSURE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; URINALYSIS;

BIOMARKERS; LUNG CANCER; N′-NITROSONORNICOTINE;

ANIMALS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; COHORT STUDIES; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; MULTIVARIATE ANALYSIS; NICOTINE; NITROSAMINES; PHENANTHRENES; RATS; RISK FACTORS; SMOKING; TOBACCO;

EID: 84895922218     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28575     Document Type: Article

References (21)

1. Hecht SS,. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998; 11: 559-603.
2. Balbo S, James-Yi S, O'Sullivan G, et al. (S)-N′- Nitrosonornicotine, a constituent of smokeless tobacco, is a potent oral tumorigen in rats. Carcinogenesis 2013; 34: 2178-83.
3. Hoffmann D, Hecht SS, Ornaf RM, et al. Nitrosonornicotine: presence in tobacco, formation and carcinogenicity, In:, Walker EA, Bogovski P, Griciute L, eds. Environmental N-nitroso compounds: analysis and formation. Lyon, France: International Agency for Research on Cancer, 1976. 307-20.
4. Hecht SS, Chen CB, Dong M, et al. Studies on non-volatile nitrosamines in tobacco. Beitr Tabakforsch Int 1977; 9: 1-6.
5. International Agency for Research on Cancer, Tobacco smoke and involuntary smoking, IARC monographs on the evaluation of carcinogenic risks to humans, vol. 83. Lyon, FR: IARC, 2004.
6. International Agency for Research on Cancer, Smokeless tobacco and tobacco-specific nitrosamines, IARC monographs on the evaluation of carcinogenic risks to humans, vol. 89. Lyon, FR: IARC, 2007.
7. American Cancer Society, Cancer facts and figures 2009 (2009).
8. Secretan B, Straif K, Baan R, et al. A review of human carcinogens-part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009; 10: 1033-34.
9. Djordjevic MV, Stellman SD, Zang E,. Doses of nicotine and lung carcinogens delivered to cigarette smokers. J Natl Cancer Inst 2000; 92: 106-11.
10. Stepanov I, Hecht SS,. Tobacco-specific nitrosamines and their N-glucuronides in the urine of smokers and smokeless tobacco users. Cancer Epidemiol Biomarkers Prev 2005; 14: 885-91.
11. Carmella SG, Akerkar S, Hecht SS,. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res 1993; 53: 721-24.
12. Yuan JM, Knezevich AD, Wang R, et al. Urinary levels of the tobacco-specific carcinogen N′-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers. Carcinogenesis 2011; 32: 1366-71.
13. Yuan JM, Koh WP, Murphy SE, et al. Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res 2009; 69: 2990-5.
14. Church TR, Anderson KE, Caporaso NE, et al. A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev 2009; 19: 260-6.
15. Hecht SS, Carmella SG, Villalta PW, et al. Analysis of phenanthrene and benzo[a]pyrene tetraol enantiomers in human urine: relevance to the bay region diol epoxide hypothesis of benzo[a]pyrene carcinogenesis and to biomarker studies. Chem Res Toxicol 2010; 23: 900-8.
16. Ross RK, Yuan JM, Yu MC, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339: 943-46.
17. Yuan JM, Ross RK, Wang XL, et al. Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA 1996; 275: 1646-50.
18. Stepanov I, Carmella SG, Briggs A, et al. Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. Cancer Res 2009; 69: 8236-40.
19. Hecht SS, Murphy SE, Stepanov I, et al. Tobacco smoke biomarkers and cancer risk among male smokers in the Shanghai Cohort Study. Cancer Lett 2012; 334: 34-8.
20. Yuan JM, Gao YT, Murphy SE, et al. Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer Res 2011; 71: 6749-57.
21. Hecht SS, Yuan JM, Hatsukami D,. Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention. Chem Res Toxicol 2010; 23: 1001-8.